Modern Diagnostic & Research Centre Ltd (BSE SME)

IPO Detail

Key performance Indicator (KPI)

Company Financial (In ₹Crore) AS PER DRHP

About Company

Incorporated in 1985, Modern Diagnostic & Research Centre Limited (MDRC) is a leading diagnostic chain in India, offering an extensive portfolio of pathology and radiology services. The company provides accurate diagnostic testing supported by home sample collection, online reporting, and customized test packages designed for both institutional clients and individual patients.

MDRC operates 21 centers across 8 states, including 17 laboratories and 4 full-service diagnostic centers, delivering services such as ultrasound, CT scans, MRI, X-rays, ECG, PFT, and specialized cardiac and neuro diagnostic testing.

Core Service Offerings

Pathology:
The company offers a comprehensive range of pathology tests, including advanced molecular diagnostics, cytogenetics, and specialized panels related to genetic disorders, oncology, and complex diseases.

Radiology:
MDRC provides high-quality imaging services supported by advanced technology, including 3-Tesla MRI, 128-slice CT scanners, digital X-rays, and ultrasound systems.

Home Sample Collection:
To enhance patient convenience, MDRC offers home blood sample collection services across multiple cities, enabling diagnostic access for patients unable to visit the centers physically.

Strength

Experienced Promoters & Strong Leadership: The company is guided by promoters with 50+ years of combined healthcare experience, supported by an experienced management team. Their strategic vision and industry expertise have strengthened the company’s growth, operations, and market positioning.

Comprehensive & Affordable Diagnostic Solutions: The company provides a one-stop diagnostic ecosystem offering a wide range of pathology and radiology services at cost-effective prices. With advanced technologies like 3T MRI, 128-slice CT, CBCT, DEXA, Mammography, and high-end molecular testing (NGS, Microarray, LCMS/MS, NIPT), patients receive seamless access to complete diagnostics under one roof.

Strong Focus on Quality & Patient Experience: Known for reliable and high-quality diagnostic services since 1985, the company maintains strong service standards, TDM capabilities, and handles high-end tests, including international samples. Patient convenience is enhanced through a mobile app, home collection services, detailed test reports, and a commitment to conclusive diagnoses through re-checks when required.

Weakness

Operational Disruptions at Labs & Centers: Any interruption at our laboratories or diagnostic centers—whether due to equipment failure, power outage, technical issues, lack of skilled staff, or external events like natural disasters or cyberattacks—can hinder our ability to process tests and negatively impact our business and financial performance.

Dependence on Brand Reputation: Since most of our revenue comes from walk-in customers, maintaining a strong brand image is critical. Any decline in service quality, accuracy, turnaround time, or patient experience—especially as we expand into new competitive markets—may adversely affect our growth and overall business.

High Dependence on Pathology Revenue: Pathology services remain our major revenue contributor. Heavy reliance on this segment poses risks, especially if demand fluctuates or competition rises. Further, if our significant investments in radiology do not generate expected returns, it may negatively impact our overall financial strategy and long-term growth.